BioCentury
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Be sure to visit the podcast's website and support the creator: www.biocentury.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android almost 10M downloads · 4.8 rating
iOS soon
Episodes
Ep. 27 - CRISPR advances and mega-IPOs: a BioCentury podcast 13.10.2020 12:39
Reach us by sending a text
Ep. 26 - Treating Trump & BMS's $13B MyoKardia buy 06.10.2020 19:59
Reach us by sending a text
Ep. 25 - Alzheimer Milestones & Vaccine Politics 29.09.2020 13:23
Reach us by sending a text
Ep. 24 - Azar's Memo & Biotech's Deals 22.09.2020 17:01
Reach us by sending a text
Ep. 23 - $21B Deal by Gilead, None by PhRMA 15.09.2020 11:40
Reach us by sending a text
Ep. 22 - Back to School, Behind the Scenes 09.09.2020 16:41
Reach us by sending a text
Ep. 21 - FDA’s Credibility on the Line, plus Biotech’s Venture Wave 01.09.2020 11:27
Reach us by sending a text
Ep. 20 - Politics & Plasma 25.08.2020 15:05
Reach us by sending a text
Ep. 19 - I Want KaNDy, Plus Sputnik V & M&A amid COVID-19 17.08.2020 14:47
Reach us by sending a text
Ep. 18 - BIOEquality, Data Sharing and Deals 10.08.2020 17:04
Reach us by sending a text
Ep. 17 - Warp Speed, Decentralized Trials & SPACs 03.08.2020 16:18
Reach us by sending a text
Ep. 16 - Trump's Ultimatum, RADx & Preclinical IPOs 27.07.2020 18:05
Reach us by sending a text
Ep. 15 - Vaccine Hopes, the Shifting Biopharma Workplace & Blueprint's Dx Deal 21.07.2020 16:17
Reach us by sending a text
Ep. 14 - Investor Sentiment, HCQ Redux and Attacking AMR 14.07.2020 13:40
Reach us by sending a text
Ep. 13 - Nuances of NASH, COVID Vaccines and Real-World Data 06.07.2020 15:07
Reach us by sending a text
Ep. 12 - Remdesivir's Price, RWD’s Moment & A Genomics Breakup 29.06.2020 11:19
Reach us by sending a text
Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access 23.06.2020 15:52
Reach us by sending a text
Ep. 10 - EUAs, ACTIV & M&A 16.06.2020 17:20
Reach us by sending a text
Ep. 9 - IPOs, Vaccines & BIO's New Leader 08.06.2020 13:49
Reach us by sending a text
Ep. 8 - Financing Flurry & Purchasing Pools 01.06.2020 13:14
Reach us by sending a text
Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs 27.05.2020 15:37
Reach us by sending a text
Ep. 6 - New Faces for COVID-19’s Next Phase, ASCO’s Hot Topics 19.05.2020 18:02
Reach us by sending a text
Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19 12.05.2020 15:22
Reach us by sending a text
Ep. 4 - End of the beginning for vaccines and the post-pandemic future 05.05.2020 15:30
BioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future. Reach us by sending a text
Ep. 3 - Surveying the Landscape for Biopharmas 28.04.2020 14:33
BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week. Reach us by sending a text
Similar podcasts
Listen to the BioCentury This Week podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
